| Treatment | Follow-up | |||||||
---|---|---|---|---|---|---|---|---|---|
 | Week 0a | Week 1 | Week 2 | Week 3 | Week 4 | Week 5 | Week 6b | 2.5 months | 4.5 months |
QEESI Life Impact | X | X | X | X | X | X | X | X | X |
QEESI Symptom severity | X | X | X | X | X | X | X | X | X |
QEESI Chemical intolerances | X | X | X | X | X | X | X | X | X |
SDS | X | X | X | X | X | X | X | X | X |
Individual tasks | X | X | X | X | X | X | X | X | X |
Noise sensitivity | X | Â | Â | Â | Â | Â | X | X | X |
SCL-92 Depressive symptoms | X | X | X | X | X | X | X | X | X |
SCL-92 Anxiety symptoms | X | X | X | X | X | X | X | X | X |
SCL-92 Somatization | X | X | X | X | X | X | X | X | X |
PSS-10 | X | X | X | X | X | X | X | X | X |
HAM-D6 | X | X | X | X | X | X | X | X | X |
WHOQOL-BREF | X | Â | Â | Â | Â | Â | X | Â | X |
Capsaicin-induced secondary hyperalgesia | X | Â | Â | Â | Â | Â | X | Â | Â |
Immunological markers | X | Â | Â | Â | Â | Â | X | Â | Â |